The hematology and medical oncology expert described the implementation of biosimilars into treating patients with breast cancer.
Megan Kruse, MD
Advertisement
Articles by Megan Kruse, MD
Advertisement
Latest Updated Articles
Megan Kruse, MD, Discusses the Use of Biosimilars in Breast Cancer TreatmentPublished: December 17th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Issues CRL for Dasatinib in CML/ALL
2
FDA Accepts Resubmission of BLA for RP1/Nivolumab in Advanced Melanoma
3
Patient With RRMM, Cytopenias, COPD, and Progressive Bone Disease
4
Raludotatug Deruxtecan Shows Promise in Platinum-Resistant Ovarian Cancer
5
